Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Hypertensive events after the initiation of contemporary cancer therapies for breast cancer control

Cancer Medicine(2022)10.1002/cam4.4862Source: DataRank Database

Hypertensive events after the initiation of contemporary cancer therapies for breast cancer control is a research paper published in Cancer Medicine (2022). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.46)OA: goldTopics (39)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Aaron P. Chum ORCID,Reynaldo Sanchez,Avirup Guha ORCID,Amit K. Dey ORCID,Raquel E. Reinbolt ORCID

Live enrichment

PubMed:35633055 PMC:PMC9844596 OpenAlex:https://openalex.org/W4281728132

NHLBI NIH HHS

Grant: K23 HL155890

NHLBI NIH HHS

Grant: R01 HL170038

National Institutes of Health

Grant: 2K12CA133250-16

OSU K12 Training Grant in Oncology

National Institutes of Health

Grant: 5K23HL155890-02

Early Detection and Mechanisms of Cancer Immunotherapy Associated Cardiotoxicity

National Institutes of Health

FWCI

0.46

Citation Percentile

0.6%

Citation Trend

2022

2023

2024

goldLicense: cc-by

journalhttps://doi.org/10.1002/cam4.4862

publisherhttps://doi.org/10.1002/cam4.4862

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.4862

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/cam4.4862

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35633055

Fields of Study

Chemotherapy-induced cardiotoxicity and mitigationCancer, Stress, Anesthesia, and Immune ResponseBlood Pressure and Hypertension Studies03 medical and health sciences0302 clinical medicine

MeSH Terms

Breast NeoplasmsFemaleHumansHypertensionUnited StatesDatabases, FactualAdverse Drug Reaction Reporting SystemsDrug-Related Side Effects and Adverse ReactionsCardiotoxicity

Keywords

MedicineIncidence (geometry)Breast cancerInternal medicineAdverse Event Reporting SystemOdds ratioAdverse effectCancerCardiotoxicityChemotherapyHypertensionNational Inpatient SampleCardio-oncologyFda Adverse Event Reporting SystemDrug-Related Side Effects and Adverse ReactionsDatabases, FactualNeoplasms. Tumors. Oncology. Including cancer and carcinogensBreast NeoplasmsUnited StatesRESEARCH ARTICLESHumansAdverse Drug Reaction Reporting SystemsFemalecardio‐oncologyRC254-282

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being